Skip to main content
. 2017 Jun 6;32(1):776–788. doi: 10.1080/14756366.2016.1256883

Table 3.

Inhibition of Aβ (1–42) self-induced aggregation and ABTS radical by target compounds.

Compound R1 R2 Aβ (1–42) aggregationinhibition (%)a ABTS assay(trolox equiv)b
5a 46.3 ± 1.6 Nc
5b 3-CH3 48.5 ± 1.8 N
5c 4-CH3 55.1 ± 1.5 N
5d 3-F 53.6 ± 2.3 N
5e 4-F 52.8 ± 1.8 N
5f 3-Br 48.8 ± 2.1 N
5g 4-Br 57.2 ± 1.1 N
5h 3,4-di-OCH3 55.7 ± 3.2 N
5i 3,4-di-OCH3 3-CH3 53.9 ± 0.9 N
5j 3,4-di-OCH3 4-CH3 63.4 ± 2.8 N
5k 3,4-di-OCH3 3-F 65.6 ± 2.3 N
5l 3,4-di-OCH3 4-F 64.7 ± 1.6 N
5m 3,4-di-OCH3 3-Br 62.8 ± 1.4 N
5n 3,4-di-OCH3 4-Br 66.3 ± 2.9 N
Curcumin 54.6 ± 2.6 1.65
a

Inhibition of Aβ (1–42) self-induced aggregation, the thioflavin-T fluorescence method was used, the mean ± SD of at least three independent experiments and the measurements were carried out in the presence of 20 μM compounds.

b

Data are expressed as (mmol trolox)/(mmol tested compound).

c

N means <0.05.